Melinda Thomas

 

 Melinda Thomas is currently the inaugural Entrepreneur in Residence for New York City. She works to build up the hard science ecosystem in New York by connecting resources and providing one on one mentoring to aspiring scientific entrepreneurs. Previous to this she was VP, Operations at CardioDx, where she took the company from day one through first product launch, with responsibility for all non-research functions. CardioDx develops and commercializes molecular based diagnostics for cardiovascular disease. It is funded by Kleiner Perkins, TPG, and MDV. Prior to CardioDx, she was the first employee and VP, Operations at ParAllele Biosciences, a high through-put genotyping and SNP discovery company. It was acquired in 2005 by Affymetrix. ParAllele was funded by Versant Ventures and MDV. Melinda holds a B.S. from U.C. Berkeley and an MBA from Harvard Business School.

Expertise:

  • Diagnostics
  • Life Sciences
  • Sequencing
  • Instrumentation
  • Team Building
  • Operation
  • Manufacturing